1. Home
  2. ICUI vs BTG Comparison

ICUI vs BTG Comparison

Compare ICUI & BTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • BTG
  • Stock Information
  • Founded
  • ICUI 1984
  • BTG 2006
  • Country
  • ICUI United States
  • BTG Canada
  • Employees
  • ICUI N/A
  • BTG N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • BTG Precious Metals
  • Sector
  • ICUI Health Care
  • BTG Basic Materials
  • Exchange
  • ICUI Nasdaq
  • BTG Nasdaq
  • Market Cap
  • ICUI 3.5B
  • BTG 4.1B
  • IPO Year
  • ICUI 1992
  • BTG N/A
  • Fundamental
  • Price
  • ICUI $142.87
  • BTG $3.01
  • Analyst Decision
  • ICUI Buy
  • BTG Buy
  • Analyst Count
  • ICUI 5
  • BTG 3
  • Target Price
  • ICUI $197.50
  • BTG $4.12
  • AVG Volume (30 Days)
  • ICUI 269.6K
  • BTG 54.7M
  • Earning Date
  • ICUI 05-08-2025
  • BTG 05-07-2025
  • Dividend Yield
  • ICUI N/A
  • BTG 4.64%
  • EPS Growth
  • ICUI N/A
  • BTG N/A
  • EPS
  • ICUI N/A
  • BTG N/A
  • Revenue
  • ICUI $2,382,046,000.00
  • BTG $1,972,693,000.00
  • Revenue This Year
  • ICUI $0.84
  • BTG $53.73
  • Revenue Next Year
  • ICUI $2.91
  • BTG N/A
  • P/E Ratio
  • ICUI N/A
  • BTG N/A
  • Revenue Growth
  • ICUI 5.44
  • BTG 2.63
  • 52 Week Low
  • ICUI $95.44
  • BTG $2.20
  • 52 Week High
  • ICUI $196.26
  • BTG $3.51
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 54.65
  • BTG 47.27
  • Support Level
  • ICUI $131.73
  • BTG $2.91
  • Resistance Level
  • ICUI $142.00
  • BTG $3.18
  • Average True Range (ATR)
  • ICUI 5.87
  • BTG 0.12
  • MACD
  • ICUI 0.68
  • BTG -0.02
  • Stochastic Oscillator
  • ICUI 89.16
  • BTG 16.67

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About BTG B2Gold Corp Common shares (Canada)

B2Gold Corp is an international, low-cost, senior gold mining company. It has three operating open-pit gold mines in Mali, Namibia, and the Philippines and numerous exploration projects across four continents. Other assets include the Gramalote and Kiaka gold projects. The company focuses on acquiring and developing interests in mineral properties with a primary focus on gold deposits as gold production forms all its revenue. There is no dependence on a particular purchaser because the gold is sold into various markets. The company's reportable operating segments include its mining operations and development projects, namely Fekola; Masbate; Otjikoto; the Goose Project, and other mineral properties; and corporate and other.

Share on Social Networks: